L’Oreal settles in patent battle over adenosine technology

L’Oreal settles in patent battle over adenosine technology

THE WHAT? L’Oreal has settled a case bought by the University of Massachusetts and Carmel Laboratories over patents relating to the French beauty giant’s use of adenosine in its Revitalift moisturizer.

THE DETAILS According to a report published by Reuters, all parties informed the Delaware federal court that their dispute had been resolved. The original case alleged that L’Oreal had infringed patents held by Carmel and Umass.

THE WHY? Reuters wrote that details of the settlement have not been published and the parties did not respond to a request for comment.

WELLNESS

FASHION

TRAVEL

PROFESSIONAL BEAUTY

JOBS & PEOPLE